LIGAND PHARMACEUTICALS INC. 12/31/03

Company

LIGAND PHARMACEUTICALS INC

Filed

February 10, 2004

Accession Number

0001102598-04-000079

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →